跳至主要内容
临床试验/NCT02165943
NCT02165943Unknown不适用

A Combined Retrospective and Prospective Protocol to Evaluate Vitoss With and Without Bone Marrow Aspirate for Benign Cavitary Lesions

Orthovita d/b/a Stryker1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Percentage of Vitoss resorption into the native bone as observed via CT

研究概览

简要总结

This is a retrospective, two-arm study reviewing the healing of cavitary defects in patients treated with Vitoss alone versus those treated with Vitoss with bone marrow aspirate (BMA). There will be a prospective follow-up visit at 24+ months to evaluate lont-term healing in patients identified during the retrospective portion of the study. It is thought that the inclusion of BMA will facilitate the resorption of the graft material, leading to better long-term bone healing.

研究设计

研究类型
Observational
观察模型
Case Control

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • males and females >/= 18 years of age at the time of surgery
  • Patients treated with Vitoss alone or Vitoss with added BMA between 2004 and 2012
  • willing and able to provide Informed Consent to participate in and follow study requirements (including a radiologic assessment)

排除标准

  • Patients with a known post-traumatic defect
  • active infection at the time of implantation
  • history of bone marrow disorders
  • contraindications to the use of supplemental BMA

结局指标

主要结局

Percentage of Vitoss resorption into the native bone as observed via CT

时间窗: minimum of 24 months post-operatively

Percentage of Vitoss resorption into the native bone will be retrospectively recorded in the Case Report Form at the 6 week, 3, 6, 12 and 18 month timepoints based on review of x-rays as well.

次要结局

  • Presence of a rim of radiolucency surrounding the grafted defect as observed by CT(minimum of 24 months post-operatively)
  • Bone trabeculation through the defect as observed by CT(minimum of 24 months post-operatively)
  • Size of the defect as observed by CT(minimum of 24 months post-operatively)
  • Persistence of graft material through the lesion as observed by CT(minimum of 24 months post-operatively)
  • Presence of graft within the soft tissue as observed by CT(minimum of 24 months post-operatively)

研究者

发起方
Orthovita d/b/a Stryker
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of Vitoss With and Without BMA for Benign... | 临床试验